These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19453934)

  • 41. Efficacy and safety of dapoxetine for the treatment of premature ejaculation: integrated analysis of results from five phase 3 trials.
    McMahon CG; Althof SE; Kaufman JM; Buvat J; Levine SB; Aquilina JW; Tesfaye F; Rothman M; Rivas DA; Porst H
    J Sex Med; 2011 Feb; 8(2):524-39. PubMed ID: 21059176
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of dapoxetine in men with premature ejaculation and concomitant erectile dysfunction treated with a phosphodiesterase type 5 inhibitor: randomized, placebo-controlled, phase III study.
    McMahon CG; Giuliano F; Dean J; Hellstrom WJ; Bull S; Tesfaye F; Sharma O; Rivas DA; Aquilina JW
    J Sex Med; 2013 Sep; 10(9):2312-25. PubMed ID: 23845016
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Dapoxetine for premature ejaculation: an updated meta-analysis of randomized controlled trials.
    Li J; Yuan H; Bai Y; Pu C; Tang Y; Dong Q; Wei Q; Han P
    Clin Ther; 2014 Dec; 36(12):2003-2014. PubMed ID: 25438723
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Patient reporting encouraged during monitoring of dapoxetine in New Zealand.
    Harrison-Woolrych M
    Drug Saf; 2011 Nov; 34(11):1115-6. PubMed ID: 21981438
    [No Abstract]   [Full Text] [Related]  

  • 45. [Dapoxetine in treatment of premature ejaculation: a systematic review].
    Wang YB; Mao Y; Wei Q; Wu TX; Dong Q
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Aug; 42(4):425-32. PubMed ID: 20721257
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Premature Ejaculation Profile: validation of self-reported outcome measures for research and practice.
    Patrick DL; Giuliano F; Ho KF; Gagnon DD; McNulty P; Rothman M
    BJU Int; 2009 Feb; 103(3):358-64. PubMed ID: 18793300
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Validity of the patient-reported Clinical Global Impression of Change as a measure of treatment response in men with premature ejaculation.
    Althof SE; Brock GB; Rosen RC; Rowland DL; Aquilina JW; Rothman M; Tesfaye F; Bull S
    J Sex Med; 2010 Jun; 7(6):2243-2252. PubMed ID: 20367770
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Premature ejaculation: treatment update.
    McCarty EJ; Dinsmore WW
    Int J STD AIDS; 2010 Feb; 21(2):77-81. PubMed ID: 20089991
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Efficacy of Dapoxetine for the treatment of premature ejaculation: a meta-analysis of randomized clinical trials on intravaginal ejaculatory latency time, patient-reported outcomes, and adverse events.
    Yue FG; Dong L; Hu TT; Qu XY
    Urology; 2015 Apr; 85(4):856-61. PubMed ID: 25817107
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Combination of Dapoxetine and Behavioral Treatment Provides Better Results than Dapoxetine Alone in the Management of Patients with Lifelong Premature Ejaculation.
    Cormio L; Massenio P; La Rocca R; Verze P; Mirone V; Carrieri G
    J Sex Med; 2015 Jul; 12(7):1609-15. PubMed ID: 26077706
    [TBL] [Abstract][Full Text] [Related]  

  • 51. An overview of pharmacotherapy in premature ejaculation.
    Porst H
    J Sex Med; 2011 Oct; 8 Suppl 4():335-41. PubMed ID: 21967395
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dapoxetine for premature ejaculation.
    Drug Ther Bull; 2014 Mar; 52(3):30-3. PubMed ID: 24627135
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Take a PAUSE for the premature ejaculation cause.
    Giuliano F
    Eur Urol; 2014 Apr; 65(4):740-1. PubMed ID: 24091022
    [No Abstract]   [Full Text] [Related]  

  • 54. [Dapoxetin (Priligy), oral].
    Duh D; Warnez M
    J Pharm Belg; 2014 Mar; (1):57-8. PubMed ID: 24804394
    [No Abstract]   [Full Text] [Related]  

  • 55. A Prospective Randomized Controlled Study to Compare Acupuncture and Dapoxetine for the Treatment of Premature Ejaculation.
    Sahin S; Bicer M; Yenice MG; Seker KG; Yavuzsan AH; Tugcu V
    Urol Int; 2016; 97(1):104-11. PubMed ID: 27049323
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Distress, disease, desire: perspectives on the medicalisation of premature ejaculation.
    Söderfeldt Y; Droppe A; Ohnhäuser T
    J Med Ethics; 2017 Dec; 43(12):865-866. PubMed ID: 28341756
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [Efficacy and tolerability of dapoxetine in the treatment of premature ejaculation].
    Yang L; Luo L; Chen XF; Fan JH; Liu RM; Wang XN; Nan XY; Zhang Y; Lin XF; Wang MZ; Xing JP; Yang ZS; Jian BL; He H; Wu DP; He DL
    Zhonghua Nan Ke Xue; 2015 Oct; 21(10):892-5. PubMed ID: 26665676
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A prospective randomized study to compare pelvic floor rehabilitation and dapoxetine for treatment of lifelong premature ejaculation.
    Pastore AL; Palleschi G; Leto A; Pacini L; Iori F; Leonardo C; Carbone A
    Int J Androl; 2012 Aug; 35(4):528-33. PubMed ID: 22320846
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Evaluation of dapoxetine treatment success in lifelong premature ejaculation patients with penile sympathetic skin response.
    Kati B; Ay H
    Andrologia; 2018 Nov; 50(9):e13076. PubMed ID: 29952430
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Results from a prospective observational study of men with premature ejaculation treated with dapoxetine or alternative care: the PAUSE study.
    Mirone V; Arcaniolo D; Rivas D; Bull S; Aquilina JW; Verze P;
    Eur Urol; 2014 Apr; 65(4):733-9. PubMed ID: 23993257
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.